Success Stories: EB-1B Petition Approved In Under Two Months for Scientist in New Jersey in the Field of Pharmaceutics

We Received EB1B Approval for a Scientist in the Field of Pharmaceutics on October 15th, 2014 (Approval Notice)


General Field: Pharmaceutics

Position at the Time of Case Filing: Scientist

Petitioner: A Private Company

Country of Origin: India

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: October 15th, 2014

Processing Time: 1 Month, 26 days

 


Case Summary:

The beneficiary on whose behalf North American Immigration Law Group was able to work in this case was a scientist in the field of pharmaceutics, whose research focused on the highly specialized topics of drug-induced liver injury and bioanalytical methods for detecting synthetic cannabinoids. His outstanding ability was attested to by an independent recommender: “[Beneficiary’s] work is distinguished by unique interdisciplinary expertise including fantastic ability with drug metabolism research, molecular biology equipment, and pharmacokinetic modeling software. Overall, [Beneficiary’s] research prowess is directed toward investigations into drug metabolism in cases of disease or inflammation. These investigations by [Beneficiary] have not only been important to science but also hold significant commercial value in terms of offering new and improved techniques for the medical and pharmaceutical industries.” The beneficiary’s highly skilled background and impressive record of achievement provided a strong case for his EB1B petition, submitted on his behalf by a private company. To disseminate his research within his scientific community, he had produced 12 peer-reviewed scientific articles as well as a book chapter and numerous conference presentations, and his body of work had received 83 citations at the time of filing from independent and leading researchers around the world, a solid indication of his work’s major significance. He had also reviewed 23 manuscripts for prominent and respected journals. It was our goal to prove that this beneficiary qualified for classification as an Outstanding Professor or Researcher, given the international recognition of his achievements; with the proof and documentation we provided, his case was approved in just one month and twenty-six days.